15th February 2022 Content supplied by: Hardy Diagnostics
Hardy Diagnostics Releases HardyCHROM™ Candida + auris
Hardy Diagnostics is pleased to announce its release of HardyCHROM™ Candida + auris, a chromogenic media recommended for the selective isolation and differential identification of Candida species. This medium allows for the identification of C. albicans, C. tropicalis, C. krusei, and the presumptive identification of C. glabrata. Colonies of C. auris will appear white with a characteristic teal to teal-green “bullseye” center. Additionally, C. auris is also differentiated from other Candida species by a unique fluorogenic reaction under UV light.
C. auris is an emerging pathogen that represents a serious multi-drug resistant (MDR) global threat. C. auris may persistently colonize the skin and hospital environment, making its transmission within and between healthcare settings more difficult to control.1 C. auris results in a wide range of mortality rates depending on the patient’s overall condition, underlying disease, geographic region, access to medical care, and age. 1
Find more information on HardyCHROM™ Candida + auris here or contact Hardy Diagnostics direct using the green "Request Information" button below.
1 Rossato, L. and A.L. Colombo. 2018. Candida auris: What Have We Learned About its Mechanisms of Pathogenicity? Frontiers in Micro.
Date Published: 15th February 2022
Source article link: View